Congenital hyperthyroidism

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue SUPPL. 4, 1997, Pages 6-11

  Krude, H ^a,d   Biebermann, H ^a   Krohn, H P ^b   Dralle, H ^c   Gruters A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Reinhard Nieter Krankenhaus Stadtische Kliniken gGmbH   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Congenital hyperthyroidism; Thyroid stimulating antibodies; TSH receptor

Indexed keywords

MATERNAL ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR;

AUTOIMMUNITY; CHILD; CONFERENCE PAPER; CRANIOFACIAL SYNOSTOSIS; DIFFERENTIAL DIAGNOSIS; FETUS DEVELOPMENT; GENE MUTATION; GOITER; GRAVES DISEASE; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; IRRITABILITY; MENTAL DEFICIENCY; MORTALITY; PATHOGENESIS; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; TACHYCARDIA; WEIGHT GAIN;

EID: 0030783743     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211924     Document Type: Conference Paper

References (16)

1. Bahn RS, Heufelder AE: Pathogenesis of Graves ophthalmopathy. N Engl J Med 329: 1468-1475, 1993
2. Danemann D, Howard NJ: Neonatal thyrotoxicosis: Intellectual impairment and craniosynostosis in later years. Journal of Pediatrics 97/2: 257-259, 1980
3. De Roux N, Polak M, Couet J: A Neomutation of the thyroid-stimulatinghormone receptor in a severe neonatal hypothyroidism. J Clin Endocrinol Metab 81: 2023-2026, 1996
4. Duprez L, Parma J, Costagliola S, Herrmanns J, Van Sande J, Dumont JE, Vassart G.: Constitutive activation of the TSH-receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett Jun 16, 409(3): 467-474, 1997
5. Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassar G: Germline mutations in thethyrotropin receptor gene cause non-autoimmune autosomal dominanthyperthyroidism. Nature Genetics 7: 396-401, 1994
6. Hollingsworth DR, Mabry CC: Congenital Graves disease. Am J Dis Child 130: 148-155, 1976
7. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G: Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332: 150-154, 1995
8. Marchant B, Brownlie BEW, Hart DM, Horton PW, Alexander WD: The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45: 1187-1193, 1977
9. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K: Antithyroid drug therapy for Graves' disease during pregnancy. N Engl J Med 315: 24-28, 1986
10. Mutjaba Q, Burrow GN: Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 46: 282-286, 1975
11. Schwab KO, Sohlemann P, Gerlich M, Von Petrykowski W, Holzapfel HP, Paschke R, Grüters A, Derwahl M: Mutations of the TSH receptor as cause of congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 104: 124-128, 1996
12. Skuza KA, Sills IN, Stene M, Rapaport R: Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. Journal of Pediatrics 128/2: 264-268, 1996
13. Thomas JL, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC: Familial hyperthyroidism without evidence of auoimmunity. Acta Endocrinol 100: 512-518, 1982
14. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J: Functional Characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81: 547-554, 1996
15. Wilroy RS: Etteldorf JN: Familial hyperthyroidism including two siblings with neonatal Graves disease. Journal of Pediatrics 78/4: 625-632, 1971
16. Zakaria M, Mc Kenzie JM, Hoffmann WH: Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 62: 368-371, 1986